Blogroll

British medical journal the Lancet on Tuesday said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump.

A study of Dutch blood donors has found that around 5.5% of them have developed antibodies against the new coronavirus, blood donation firm Sanquin said on Wednesday.

Thailand on Wednesday reported one new coronavirus infection and no new deaths, bringing the country's total to 3,084 confirmed cases and 58 fatalities since the outbreak started in January.

South Korea said on Wednesday it has approved the emergency use of Gilead Sciences Inc's remdesivir to treat COVID-19 after a government panel last week cited positive results for the anti-viral drug in other countries.

The number of confirmed coronavirus cases in Germany increased by 342 to 182,370, data from the Robert Koch Institute (RKI) for infectious diseases showed on Wednesday.

Google was sued on Tuesday in a proposed class action accusing the internet search company of illegally invading the privacy of millions of users by pervasively tracking their internet use through browsers set in "private" mode.

An advocacy group backed by the tech industry sued President Donald Trump on Tuesday over his executive order that would weaken a law protecting online platforms including social media companies that label or fact-check his posts.

Facebook CEO Mark Zuckerberg told employees on Tuesday that he stood by his decision not to challenge inflammatory posts by U.S. President Donald Trump, refusing to give ground a day after staff members staged a rare public protest.

Two of Canada's largest telecoms firms on Tuesday teamed with Sweden's Ericsson and Finland's Nokia Oyj to build fifth-generation (5G) telecoms networks, ditching China's Huawei Technologies for the project.

Zoom Video Communications Inc nearly doubled its expectations for annual sales on Tuesday, driven by a surge in users as more people work from home and connect with friends online during coronavirus lockdowns.

Twitter Inc on Tuesday appointed Patrick Pichette, a former chief financial officer at Google, as the social network's board chairman, marking the first time in Twitter's history that an outsider will preside over the group.

Google was sued on Tuesday in a proposed class action accusing the internet search company of illegally invading the privacy of millions of users by tracking their internet use from browsers set in "private" browsing mode.

The use of batteries for energy storage is expected to grow faster than that of other flexible assets in the period to 2030 and beyond, as renewable energy generation expands, consultancy Wood Mackenzie said in research published on Wednesday.

A proposed European cloud computing platform that seeks to break the continent's reliance on Silicon Valley will take shape in the coming weeks when a group of 22 French and German companies set up a legal entity to run it.

Zoom Video Communications Inc nearly doubled its expectations for annual sales on Tuesday, driven by a surge in users as more people work from home and connect with friends online during coronavirus lockdowns.

Twitter Inc said on Tuesday that it appointed Patrick Pichette, former chief financial officer at Google, as chairman, replacing Omid Kordestani.

Ride-hailing firm Lyft Inc said on Tuesday that rides on its platform rose 26% in May from the previous month helped by strong growth in cities where coronavirus-induced restrictions have been eased.

British medical journal the Lancet on Tuesday said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump.

The U.S. Food and Drug Administration has extended the review period for Novartis AG's multiple sclerosis drug ofatumumab by three months, the company said on Tuesday.

A senior U.S. Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine could be available to part of the U.S. population by the end of the year.